Clinical Trial Update: Efficacy and Safety of Lu AA34893 in Patients With Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial of Lu AA34893 for Major Depressive Disorder has been terminated; no efficacy or safety results are provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Lu AA34893

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder | Phase 2 | Status: TERMINATED